Tandem Diabetes Care, Inc. (FRA:TD5A)
Germany · Delayed Price · Currency is EUR 16.43
+0.62 (3.89%)
At close: Jan 30, 2026
Tandem Diabetes Care Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -203.37 | -96.03 | -222.61 | -94.59 | 15.57 | -34.38 |
Depreciation & Amortization | 17.42 | 16.61 | 15.72 | 14.33 | 13.85 | 10.45 |
Other Amortization | 1.92 | 2.09 | 2.2 | 1.9 | 1.73 | 10.1 |
Loss (Gain) From Sale of Assets | 2 | 2 | - | - | - | - |
Asset Writedown & Restructuring Costs | 81.91 | - | 92.85 | 31.04 | - | - |
Loss (Gain) From Sale of Investments | -3.81 | -2.32 | 3.59 | 4.19 | 0.37 | -1.3 |
Loss (Gain) on Equity Investments | 11.69 | 2.05 | - | - | - | - |
Stock-Based Compensation | 100.44 | 101.38 | 88.08 | 84.92 | 60.75 | 58.43 |
Provision & Write-off of Bad Debts | 9.42 | 9.98 | 5.54 | 4.78 | 2.33 | 3.02 |
Other Operating Activities | -3.6 | 0.24 | 0.52 | 8.56 | 2.4 | 14.94 |
Change in Accounts Receivable | -26.88 | -20.8 | 4.28 | -7.83 | -30.98 | -38.84 |
Change in Inventory | 17.85 | 5.81 | -46.05 | -42.45 | -4.95 | -15.36 |
Change in Accounts Payable | -5.03 | -2.39 | -4.86 | 24.49 | 10.28 | 1.12 |
Change in Unearned Revenue | -35.25 | -34.74 | 21.53 | 8.36 | 10.61 | 7.03 |
Change in Other Net Operating Assets | 26.49 | 40.33 | 7.43 | 12.78 | 29.42 | 9.46 |
Operating Cash Flow | -8.79 | 24.23 | -31.81 | 50.46 | 111.36 | 24.67 |
Operating Cash Flow Growth | - | - | - | -54.68% | 351.41% | -41.13% |
Capital Expenditures | -16.33 | -19.23 | -26.8 | -34.1 | -14.18 | -27.41 |
Cash Acquisitions | - | - | -69.5 | -25.72 | - | - |
Sale (Purchase) of Intangibles | -43.46 | - | - | - | -9.33 | -4.89 |
Investment in Securities | 152.66 | -4.25 | 10.56 | 92.99 | -163.37 | -263.76 |
Investing Cash Flow | 92.86 | -23.48 | -85.74 | 33.17 | -186.88 | -296.06 |
Long-Term Debt Issued | - | 316.25 | - | - | - | 278.69 |
Long-Term Debt Repaid | - | -246.12 | - | - | - | - |
Net Debt Issued (Repaid) | -40.76 | 70.13 | - | - | - | 278.69 |
Issuance of Common Stock | - | - | 4.18 | 17.47 | 51.93 | 69.82 |
Repurchase of Common Stock | -2.91 | -36.73 | - | - | - | - |
Other Financing Activities | - | -25.03 | -0.07 | -0.59 | - | -34.07 |
Financing Cash Flow | -43.67 | 8.37 | 4.11 | 16.88 | 51.93 | 314.44 |
Foreign Exchange Rate Adjustments | 2.51 | 1.26 | -0.21 | 0.83 | 0.15 | 0.39 |
Net Cash Flow | 42.91 | 10.37 | -113.65 | 101.34 | -23.43 | 43.44 |
Free Cash Flow | -25.13 | 4.99 | -58.61 | 16.37 | 97.18 | -2.74 |
Free Cash Flow Growth | - | - | - | -83.16% | - | - |
Free Cash Flow Margin | -2.50% | 0.53% | -7.84% | 2.04% | 13.83% | -0.55% |
Free Cash Flow Per Share | -0.38 | 0.08 | -0.90 | 0.26 | 1.51 | -0.04 |
Cash Interest Paid | 3.08 | 3.08 | 7.57 | 4.31 | 4.31 | 2.71 |
Cash Income Tax Paid | 6.74 | 3.1 | 1.92 | 0.41 | 0.26 | 0.18 |
Levered Free Cash Flow | 13.04 | 38.15 | -35.7 | 8.76 | 55.93 | -17.55 |
Unlevered Free Cash Flow | 15.93 | 40.69 | -31.72 | 10.75 | 57.98 | -19.65 |
Change in Working Capital | -22.82 | -11.78 | -17.69 | -4.65 | 14.37 | -36.59 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.